JP2025507192A - アベルモスカスマニホット花のフラボノイド有効部位およびその調製方法並びに用途 - Google Patents

アベルモスカスマニホット花のフラボノイド有効部位およびその調製方法並びに用途 Download PDF

Info

Publication number
JP2025507192A
JP2025507192A JP2024554801A JP2024554801A JP2025507192A JP 2025507192 A JP2025507192 A JP 2025507192A JP 2024554801 A JP2024554801 A JP 2024554801A JP 2024554801 A JP2024554801 A JP 2024554801A JP 2025507192 A JP2025507192 A JP 2025507192A
Authority
JP
Japan
Prior art keywords
quercetin
extract
abelmoschus
manii
flower
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024554801A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507192A5 (cg-RX-API-DMAC7.html
Inventor
海涛 唐
丹丹 王
海涛 葛
殿広 王
小蘭 彭
慧 梁
富江 王
Original Assignee
蘇中薬業集団股▲ふん▼有限公司
江蘇蘇中薬業研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 蘇中薬業集団股▲ふん▼有限公司, 江蘇蘇中薬業研究院有限公司 filed Critical 蘇中薬業集団股▲ふん▼有限公司
Publication of JP2025507192A publication Critical patent/JP2025507192A/ja
Publication of JP2025507192A5 publication Critical patent/JP2025507192A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medical Informatics (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2024554801A 2022-03-15 2022-03-15 アベルモスカスマニホット花のフラボノイド有効部位およびその調製方法並びに用途 Pending JP2025507192A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2022/080818 WO2023173268A1 (zh) 2022-03-15 2022-03-15 一种黄蜀葵花黄酮类有效部位及其制备方法与应用

Publications (2)

Publication Number Publication Date
JP2025507192A true JP2025507192A (ja) 2025-03-13
JP2025507192A5 JP2025507192A5 (cg-RX-API-DMAC7.html) 2026-04-08

Family

ID=88022021

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024554801A Pending JP2025507192A (ja) 2022-03-15 2022-03-15 アベルモスカスマニホット花のフラボノイド有効部位およびその調製方法並びに用途

Country Status (5)

Country Link
US (1) US20250195598A1 (cg-RX-API-DMAC7.html)
EP (1) EP4494646A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025507192A (cg-RX-API-DMAC7.html)
CN (1) CN118973595A (cg-RX-API-DMAC7.html)
WO (1) WO2023173268A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025055910A1 (zh) * 2023-09-16 2025-03-20 苏中药业集团股份有限公司 一种药物组合物在制备骨质疏松药物中的应用
CN118894949B (zh) * 2024-09-30 2025-01-24 临沂大学 一种金花葵籽中多糖的提取、纯化方法及其应用
CN122297505B (zh) * 2026-05-20 2026-08-11 苏中药业集团股份有限公司 一种药物组合物及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994337A (zh) * 2006-11-11 2007-07-11 周亚球 黄蜀葵花总黄酮提取物、其制备及应用
CN102319275A (zh) * 2011-09-15 2012-01-18 江苏苏中药业集团股份有限公司 黄蜀葵花提取物、制剂及其制备方法
CN108567802A (zh) * 2018-07-25 2018-09-25 江苏苏中药业集团股份有限公司 一种黄蜀葵花黄酮类有效部位及其制备方法与应用
CN111920836A (zh) * 2019-06-13 2020-11-13 江苏苏中药业集团股份有限公司 一种黄蜀葵花提取物在制备治疗纤维化药物中的应用
CN112870236A (zh) * 2019-11-29 2021-06-01 江苏苏中药业集团股份有限公司 一种黄蜀葵花黄酮类有效部位及其制备方法与应用
CN112972508A (zh) * 2020-04-16 2021-06-18 江苏苏中药业集团股份有限公司 黄蜀葵花提取物作为trpc离子通道抑制剂的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107519220A (zh) * 2017-09-15 2017-12-29 江苏苏中药业集团股份有限公司 一种黄蜀葵花中黄酮类化合物的提取方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994337A (zh) * 2006-11-11 2007-07-11 周亚球 黄蜀葵花总黄酮提取物、其制备及应用
CN102319275A (zh) * 2011-09-15 2012-01-18 江苏苏中药业集团股份有限公司 黄蜀葵花提取物、制剂及其制备方法
CN108567802A (zh) * 2018-07-25 2018-09-25 江苏苏中药业集团股份有限公司 一种黄蜀葵花黄酮类有效部位及其制备方法与应用
CN111920836A (zh) * 2019-06-13 2020-11-13 江苏苏中药业集团股份有限公司 一种黄蜀葵花提取物在制备治疗纤维化药物中的应用
CN112870236A (zh) * 2019-11-29 2021-06-01 江苏苏中药业集团股份有限公司 一种黄蜀葵花黄酮类有效部位及其制备方法与应用
CN112972508A (zh) * 2020-04-16 2021-06-18 江苏苏中药业集团股份有限公司 黄蜀葵花提取物作为trpc离子通道抑制剂的用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHONGGUO ZHONGXIYI JIEHE ZAZHI, vol. 40, no. 8, JPN7025003383, August 2020 (2020-08-01), pages 901 - 907, ISSN: 0005652510 *

Also Published As

Publication number Publication date
US20250195598A1 (en) 2025-06-19
WO2023173268A1 (zh) 2023-09-21
EP4494646A4 (en) 2026-02-18
CN118973595A (zh) 2024-11-15
EP4494646A1 (en) 2025-01-22

Similar Documents

Publication Publication Date Title
US20250195598A1 (en) Flavonoid active fraction of an abelmoschi corolla, preparation method and application thereof
WO2021203614A1 (zh) 一种治疗冠状病毒性疾病的药物组合物及其制备方法和用途
JP2025507192A5 (cg-RX-API-DMAC7.html)
WO2017113649A1 (zh) 罗汉果提取物抗肺纤维化的应用
CN106474185A (zh) 一种紫苏叶提取物及其组合物在制备降低血尿酸的药物或食品中的应用
CN117298095B (zh) 野马追倍半萜内酯类化合物在制备用于治疗/预防nlrp3炎性小体介导疾病药物的应用
CN117582459A (zh) 一种黄蜀葵花提取物在制备治疗和/或预防溃疡性疾病的药物中的应用
CN111450136A (zh) 一种牡蛎葛根复合颗粒及其制备方法
US20230057861A1 (en) Use of corydalis saxicola bunting and formulation thereof in preparation of drug for treating non-alcoholic fatty liver diseases
WO2016150380A1 (zh) 一种含有水飞蓟宾的药物组合
CN118634232A (zh) 一种药物组合物在制备治疗和/或预防皮肤疾病的药物中的应用
CN102058567A (zh) 3′, 4-二羟基-3, 5′-二甲氧基联苄在制备治疗白内障的药物中的应用
CN111700892B (zh) 五味子乙素抗prrsv的用途
CN100594913C (zh) 治疗糖尿病及其并发症的药物组合物及其制备方法和用途
CN106562985A (zh) 蒙花苷的医药保健用途
CN101278940A (zh) 用于治疗糖尿病性心血管病变的药物组合物及其制备方法
WO2023174205A1 (zh) 一种药物制剂及其应用
CN107334757B (zh) 丹酚酸a作为防治糖尿病眼病药物的用途
CN116036153B (zh) 啤酒花提取物在制备用于治疗或者预防抑郁症、抑郁症并发症、焦虑症的产品中的应用
CN115887513B (zh) 无瓣海桑嫩枝叶提取物在制备高尿酸血症药物中的应用
CN101797348B (zh) 一种治疗增生性玻璃体视网膜病变的中药
CN121221733B (zh) 一种预防和/或治疗酒精性肝病的药食同源中药组合物
CN118903345B (zh) 防治耳聋的药物在制备防治化学性肝损伤药物中的应用
JP4012814B2 (ja) 苦蕎麦を原料とするアルドース還元酵素阻害剤及びソルビトール降下剤
CN119015305B (zh) 红景天多糖、制备方法及其在制备治疗慢性肾炎药物中的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241016

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241016

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250723

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250729

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251017

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251225

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20260114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20260803